Analysis of Nucleoporin 107 Overexpression and Its Association with Prognosis and Immune Infiltration in Lung Adenocarcinoma by Bioinformatics Methods

被引:0
作者
Li, Zi-Hao [1 ]
Li, Jia-Yi [2 ]
Zhu, Yong-Jie [1 ,3 ]
Dai, Lei [3 ]
Wu, Zuo-Tao [3 ]
Nong, Ju-Sen [4 ]
Zhuo, Ting [5 ]
Li, Fu-Lu [1 ]
He, Ling-Yun [1 ]
Liang, Hong -Hua [1 ]
Zang, Feng-Ling [1 ]
Wang, Yong-Yong [3 ]
Chen, Ming -Wu [3 ]
Huang, Wei-Jia [1 ]
Cao, Jian-Bin [1 ]
机构
[1] Guangxi Med Univ, Liuzhou Peoples Hosp, Dept Thorac Surg, Dept Hepatobiliary Surg, Liuzhou, Guangxi, Peoples R China
[2] Guangxi Med Univ, Liuzhou Peoples Hosp, Dept Nephrol, Liuzhou, Guangxi, Peoples R China
[3] Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanning, Guangxi, Peoples R China
[4] Guangxi Med Univ, Affiliated Hosp 1, Dept Pediat Surg, Nanning, Peoples R China
[5] Guangxi Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanning, Guangxi, Peoples R China
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2023年 / 16卷
关键词
lung adenocarcinoma; nucleoporin; 107; immune infiltration; tumor mutation burden; TP53; immune checkpoint; CANCER; SIGNATURE; TIGIT; LAG-3;
D O I
10.2147/IJGM.S441185
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Lung adenocarcinoma (LUAD) has high morbidity and mortality. Current studies indicate nucleoporin 107 (NUP107) is involved in the construction of nuclear pore complex, and NUP107 overexpression contributes to the growth and development in most types of cancers, but its effect in LUAD has not been elucidated. Methods: Differences in NUP107 expression were investigated using the Cancer Genome Atlas (TCGA) and multiple Gene Expression Omnibus (GEO) data sets. Enrichment analysis were implemented to probe the NUP107 function. The association of NUP107 with the degree of immune cell infiltration was investigated by the TIMER database, single-sample gene set enrichment analysis (ssGSEA), and ESTIMATE. The association of NUP107 expression with tumor mutation burden (TMB), TP53, and immune checkpoint was analyzed. Single-cell RNA sequencing data were used to detect NUP107 expression in different cell clusters. Finally, we performed real-time quantitative polymerase chain reaction (RT-qPCR) and immunohistochemistry (IHC) to prove the difference of NUP107 expression.Results: NUP107 was overexpressed in LUAD and mainly expressed in cancer stem cell (CSC). Overexpression of NUP107 in LUAD suggested a poorer prognosis. Functional enrichment analysis pointed out that NUP107 was mainly linked to the regulation of cell cycle. Both immune cell infiltration and TMB were found to be in connection with NUP107. Cases in the group with high NUP107 expression had poorer immune infiltration, but had higher expression of immune checkpoints, TMB, and proportion of TP53 mutations.Conclusion: NUP107 is a sensitive diagnostic and prognostic factor for LUAD and may be involved in tumor progression through its effects on cell cycle and immune infiltration.
引用
收藏
页码:5449 / 5465
页数:17
相关论文
共 47 条
  • [1] Single nucleotide variant in Nucleoporin 107 may be predictive of sensitivity to chemotherapy in patients with ovarian cancer
    Alanee, Shaheen
    Delfino, Kristin
    Wilber, Andrew
    Robinson, Kathy
    Brard, Laurent
    Semaan, Assaad
    [J]. PHARMACOGENETICS AND GENOMICS, 2017, 27 (07) : 264 - 269
  • [2] Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
    Anderson, Ana C.
    Joller, Nicole
    Kuchroo, Vijay K.
    [J]. IMMUNITY, 2016, 44 (05) : 989 - 1004
  • [3] Cytochrome P450-Mediated Pulmonary Metabolism of Carcinogens Regulation and Cross-Talk in Lung Carcinogenesis
    Anttila, Sisko
    Raunio, Hannu
    Hakkola, Jukka
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2011, 44 (05) : 583 - 590
  • [4] Mast cell-based molecular subtypes and signature associated with clinical outcome in early-stage lung adenocarcinoma
    Bao, Xuanwen
    Shi, Run
    Zhao, Tianyu
    Wang, Yanfang
    [J]. MOLECULAR ONCOLOGY, 2020, 14 (05) : 917 - 932
  • [5] Targeting the microenvironment in solid tumors
    Belli, Carmen
    Trapani, Dario
    Viale, Giulia
    D'Amico, Paolo
    Duso, Bruno Achutti
    Della Vigna, Paolo
    Orsi, Franco
    Curigliano, Giuseppe
    [J]. CANCER TREATMENT REVIEWS, 2018, 65 : 22 - 32
  • [6] Noncoding RNA:RNA Regulatory Networks in Cancer
    Chan, Jia Jia
    Tay, Yvonne
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [7] Comprehensive analysis of ZFPM2-AS1 prognostic value, immune microenvironment, drug sensitivity, and co-expression network: from gastric adenocarcinoma to pan-cancers
    Chen, Di
    Wang, Mengmeng
    Jiang, Xin
    Xiong, Zhifan
    [J]. DISCOVER ONCOLOGY, 2022, 13 (01)
  • [8] The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines)
    De Giglio, Andrea
    Di Federico, Alessandro
    Nuvola, Giacomo
    Deiana, Chiara
    Gelsomino, Francesco
    [J]. CURRENT ONCOLOGY REPORTS, 2021, 23 (11)
  • [9] The Treg/Th17 Paradigm in Lung Cancer
    Duan, Min-Chao
    Zhong, Xiao-Ning
    Liu, Guang-Nan
    Wei, Jin-Ru
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2014, 2014
  • [10] Immunotherapy in colorectal cancer: rationale, challenges and potential
    Ganesh, Karuna
    Stadler, Zsofia K.
    Cercek, Andrea
    Mendelsohn, Robin B.
    Shia, Jinru
    Segal, Neil H.
    Diaz, Luis A., Jr.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (06) : 361 - 375